HAL (France)open access
Biologics vs JAK Inhibitors for Moderate-to-Severe Atopic Dermatitis. Long-Term Efficacy and Safety: A Systematic Review
Lebrikizumab, Long-term safety, Dupilumab, Biologics, Atopic dermatitis, Tralokinumab, 1, Systematic review
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 427395
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.